EFFECT OF HIGH INTENSITY LASER IN PATELLOFEMORAL PAIN SYNDROME (Laser)

October 11, 2021 updated by: ozluozge, Istanbul Medipol University Hospital

EFFECT OF HIGH INTENSITY LASER THERAPY ON PAIN AND LOWER EXTREMITY FUNCTION IN PATELLOFEMORAL PAIN SYNDROME

The aim of this study is to investigate the effectiveness of high-intensity laser therapy on pain and lower extremity function in the treatment of patellofemoral pain syndrome.

Study Overview

Detailed Description

Participants between the ages of 25-45 who were diagnosed with Unilateral patellofemoral pain syndrome by the doctor will be included in the study. Also positive Clarke's test and patellar compression tests will be determined as inclusion criteria. The 45 participants will be randomly divided into three groups. Both groups will receive 2 weeks (5 sessions per week) of therapy. First group patients underwent High Intensity Laser Therapy (HILT) and exercises. Second group patients will be treated by transcutaneous electrical nerve stimulation(TENS), ultrasound (US) and exercise for 10 sessions. Also In the third group patients will be treated with ultrasound (US),interferential current stimulation and exercise. All groups receive the same exercise exercise protocol including muscle strengthening and flexibility training for 12 weeks. The outcomes will be pain intensity measured by visual analog scale (VAS) , knee flexion range of motion (FROM), timed up and go test (TUG),muscle strength measured with handheld dynamometer, Pressure Pain Threshold with an algometry and functionality of knee measured by the Lower extremity functional scale and Kujala patellofemoral questionnaire. Statistical analyzes will be performed to compare amounts at baseline, immediately after treatment, and after 12 weeks.

Study Type

Interventional

Enrollment (Anticipated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beykoz
      • Istanbul, Beykoz, Turkey, 34820
        • Ozge Ozlu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Unilateral patellofemoral pain syndrome diagnosed by a doctor
  • 25-45 years old
  • pain from prolonged sitting, climbing and descending stairs, running,knee bend more than 3 months
  • positive patellar compression and clarke's tests.

Exclusion Criteria:

  • Previous knee pain, trauma, surgery and other joint diseases,
  • Knee ligament, bursa, meniscus and synovial fold injury or dysfunction
  • Osteoarthritis in the knee joint,
  • Neurological problems that may affect walking
  • Pregnancy
  • No chronic disease
  • Malignancy,
  • Presence of infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Intensity Laser Therapy Group
Patients underwent High Intensity Laser Therapy (HILT) and exercise for 10 sessions
High Intensity Laser Therapy (HILT) and exercises will be used.
Experimental: Ultrasound and Transcutaneous Electrical Nerve Stimulation Group
Patients will be treated by transcutaneous electrical nerve stimulation(TENS), ultrasound (US) and exercise for 10 sessions
Transcutaneous electrical nerve stimulation(TENS), ultrasound (US) will be applied.
Experimental: Ultrasound and Interferential Current Stimulation Group
Patients will be treated with ultrasound (US) ,interferential current stimulation and exercise for 10 sessions
Ultrasound (US) ,interferential current stimulation and exercise will be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain status
Time Frame: 5 minutes
Pain intensity was evaluated with visual analog scale (VAS) in two conditions during activity and resting time. This method, which is developed to determine the intensity of pain to indicate by numbers. It begins with the absence of pain (0) on numerical scale and ends the level of unbearable pain
5 minutes
Range of motion assesment
Time Frame: 10minutes
Universal goniometer will used to measure the joint position and joint range of motion measurements based on Kendall and American Association of Orthopedic Surgeons. The participant will in the sitting position and asked to perform active cervical region flexion, extension, right and left rotation, right and left lateral flexion of the neck movements and performed degrees will recorded
10minutes
Functionality
Time Frame: 5 minutes
The patients will asked to start from a sitting position in a chair, to get up at the command given, to walk the predetermined distance of 3 meters as fast as they could, and to return to their seats. The time from the time they got up from the chair and sat down again will recorded with a stopwatch. Measurements will be repeated 3 times and the average will be recorded in seconds (sec).
5 minutes
Muscle stength assesment
Time Frame: 10 minutes
A myometer will be used to measure the strength of the hamstring and quadriceps muscle groups of all participants. Myometer is an evaluation method that objectively evaluates muscle strength and gives more sensitive results than manual muscle testing.
10 minutes
Pain threshold assessment
Time Frame: 10 minutes
Pressure pain threshold measurement will be measured with an algometer device. Algometers are a device that can be used to define pressure and pressure pain threshold.
10 minutes
Severity and function of patellofemoral pain
Time Frame: 5 minutes
It will be evaluated with the 'Kujala patellofemoral score' system. These scoring system values range from 100 (normal, pain-free, fully functional knee) to 0 (severe knee pain and dysfunction).
5 minutes
Function of lower extremity
Time Frame: 10 minutes
A lower extremity function test will be used to measure lower extremity functionality. It is a test used to measure the functional status of the lower extremities.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: OZGE OZLU, Medipol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2021

Primary Completion (Anticipated)

March 10, 2022

Study Completion (Anticipated)

June 10, 2022

Study Registration Dates

First Submitted

September 29, 2021

First Submitted That Met QC Criteria

October 11, 2021

First Posted (Actual)

October 12, 2021

Study Record Updates

Last Update Posted (Actual)

October 12, 2021

Last Update Submitted That Met QC Criteria

October 11, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • ozgeozlu

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

When I published this manuscript in a journal, I would share the results of inividuald participant data of this study with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic Disorder

Clinical Trials on High Intensity Laser Therapy Group

Subscribe